Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

Article  PubMed  Google Scholar 

Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021;39:1485–505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Minckwitz G, Untch M, Blohmer JU, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30:1796–804.

Article  Google Scholar 

Burstein HJ, Curigliano G, Thurlimann B, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32:1216–35.

Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:691–722.

Zhou Q, Dong J, Sun Q, et al. Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis. BMJ Open. 2021;11:e047957.

Article  PubMed  PubMed Central  Google Scholar 

Bae SJ, Cha YJ, Yoon C, et al. Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy. Sci Rep. 2020;10:13078.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma R, Wei W, Ye H, et al. A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy. BMC Cancer. 2023;23:245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murray C, Flanagan L, D’Arcy C, et al. Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma. Virchows Arch. 2020;476:367–72.

Article  CAS  PubMed  Google Scholar 

Giuliano AE, Edge SB, Hortobagyi GN. Eighth edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018;25:1783–5.

Article  PubMed  Google Scholar 

Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384:164–72.

Article  PubMed  Google Scholar 

Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342:1266–71.

Article  CAS  PubMed  Google Scholar 

Afify SM, Tabll A, Nawara HM, et al. Five fibrosis biomarkers together with serum ferritin level to diagnose liver fibrosis and cirrhosis. Clin Lab. 2018;64:1685–93.

Article  PubMed  Google Scholar 

Allison R, Guraka A, Shawa IT, et al. Drug-induced liver injury: a 2023 update. J Toxicol Environ Health B Crit Rev. 2023;26:442–67.

Article  CAS  PubMed  Google Scholar 

Gerussi A, Natalini A, Antonangeli F, et al. Immune-mediated drug-induced liver injury: immunogenetics and experimental models. Int J Mol Sci. 2021;22:4557.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrade RJ, Chalasani N, Bjornsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5:58.

Article  PubMed  Google Scholar 

Byrne A, Savas P, Sant S, et al. Tissue-resident memory T cells in breast cancer control and immunotherapy responses. Nat Rev Clin Oncol. 2020;17:341–8.

Article  PubMed  Google Scholar 

Pilipow K, Darwich A, Losurdo A. T cell-based breast cancer immunotherapy. Semin Cancer Biol. 2021;72:90–101.

Article  CAS  PubMed  Google Scholar 

Denkert C, von Minckwitz G, Darb-Esfahani S, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19:40–50.

Article  PubMed  Google Scholar 

Wang K, Xu J, Zhang T, Xue D. Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: a meta-analysis. Oncotarget. 2016;7:44288–98.

Article  PubMed  PubMed Central  Google Scholar 

Corti A, Franzini M, Paolicchi A, Pompella A. Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance, and drug targeting. Anticancer Res. 2010;30:1169–81.

CAS  PubMed  Google Scholar 

Marhold M, Udovica S, Halstead A, et al. Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer. Oncoimmunology. 2023;12:2275846.

Article  PubMed  PubMed Central  Google Scholar 

Passat T, Touchefeu Y, Gervois N, et al. Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1, and anti-PD-L1 antibodies in cancer treatment. Bull Cancer. 2018;105:1033–41.

Rogado J, Sanchez-Torres JM, Romero-Laorden N, et al. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients. Eur J Cancer. 2019;109:21–7.

Article  CAS  PubMed  Google Scholar 

Strasak AM, Rapp K, Brant LJ, et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008;68:3970–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Hemelrijck M, Jassem W, Walldius G, et al. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons: the Swedish AMORIS study. Eur J Cancer. 2011;47:2033–41.

Article  PubMed  Google Scholar 

Preyer O, Johansen D, Holly J, et al. Gamma-glutamyltransferase and breast cancer risk beyond alcohol consumption and other lifestyle factors: a pooled cohort analysis. PLoS One. 2016;11:e0149122.

Article  PubMed  PubMed Central  Google Scholar 

Seol A, Wang W, Kim SI, et al. Enhanced susceptibility to breast cancer in Korean women with elevated serum gamma-glutamyltransferase levels: a nationwide population-based cohort study. Front Oncol. 2021;11:668624.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun L, Yin W, Wu Z, et al. The predictive value of pre-therapeutic serum gamma-glutamyl transferase in efficacy and adverse reactions to neoadjuvant chemotherapy among breast cancer patients. J Breast Cancer. 2020;23:509–20.

Article  PubMed  PubMed Central  Google Scholar 

Chen HL, Chen Q, Deng YC. Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer. Med Baltim. 2021;100:e27632.

Article  CAS  Google Scholar 

Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112:18–35.

Article  CAS  PubMed  Google Scholar